As health care organizations progress toward value-based health care and PHM, the US market for enterprise solutions is evolving into a lucrative space where favorable regulatory structures and the obsolescence of legacy HCIT infrastructure will promote robust growth through 2028.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for enterprise solutions in the US across a 10-year period.
VNA technology is increasingly regarded as the future keystone in HCIT structures and will eventually become the most lucrative enterprise solution segment.
What are the key differences that separate VNA and enterprise PACS, and how do these differences contribute to the value proposition of each technology?
What factors contribute to the growth of the VNA and enterprise PACS segments?
When will the VNA segment overtake the enterprise PACS segment in revenues?
Vendors of enterprise solutions must develop new competitive strategies to address the evolving purchasing priorities and needs of health care facilities.
How will merger and acquisitions change the competitive landscape of enterprise solutions?
How will hospital consolidation and declining physician influence affect purchasing decisions for enterprise solutions? Which enterprise solution vendors will benefit the most from this changing landscape?
How can traditional PACS vendors position themselves in a market that increasingly prioritizes vendor neutrality and interoperability between IT solutions?
How will AI integration affect the competitiveness of certain companies?
What should dedicated image exchange solution vendors do in order to stay relevant in a market with rapidly changing preferences? What advantages do they have against enterprise solution vendors?
Government incentive programs, namely the update of the existing Meaningful Use incentive program into the Promoting Interoperability program and MACRA, have created a basis for widespread HCIT adoption.
How will the long-term goals of the Promoting Interoperability program and MACRA affect the adoption of enterprise solution technologies?
How will government incentive programs shift purchasing priorities between VNA, enterprise PACS, and dedicated image exchange solutions?
How will the direction of future government legislation affect the competitive dynamics within the market?
- Enterprise Solutions - Market Insights - United States
Author(s): Sumit Jain, MS Pharm
Sumit Jain is an analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, focusing on diagnostic imaging capital equipment and healthcare IT markets. Sumit holds a Bachelor's degree in Pharmacy from the Rajiv Gandhi Technical University, Bhopal, and a Master's degree in Pharmacoinformatics from the National Institute of Pharmaceutical Education and Research, Mohali.